Adipose-Derived Regenerative Cells in Ischemic Cardiomyopathy
Adipose-Derived Regenerative Cells in Ischemic Cardiomyopathy
Our findings indicate that obtaining autologous ADRCs via liposuction and delivering them by transendocardial injection are safe and feasible in patients with ischemic cardiomyopathy. Moreover, our trial provides a sound basis for testing the efficacy of ADRC therapy in a larger group of patients with chronic myocardial ischemia.
Conclusion
Our findings indicate that obtaining autologous ADRCs via liposuction and delivering them by transendocardial injection are safe and feasible in patients with ischemic cardiomyopathy. Moreover, our trial provides a sound basis for testing the efficacy of ADRC therapy in a larger group of patients with chronic myocardial ischemia.